Abstract
This pilot study aimed to use Ciphergen ProteinChip® technology to determine differences in protein profiles in plasma, taken at 26 weeks, from women at risk of developing pre-eclampsia. Five proteins were found to be significantly up-regulated in samples from women who subsequently developed pre-eclampsia compared with women who remained normotensive.
Original language | English |
---|---|
Pages (from-to) | 873-874 |
Number of pages | 2 |
Journal | Journal of Obstetrics & Gynaecology |
Volume | 24 |
Issue number | 8 |
DOIs | |
Publication status | Published - 2004 |